OC
OCS.O
—
NASDAQ
Pharmaceuticals
Ocs.O
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
800,3M USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
-50,5 %
Net margin
—
Debt / equity
0,01
Beta
—
52w range
—
Volume
3,1k
Day range
$28,99–$29,98
Prev close
$29,61
Open
$29,66
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
OCS.O is a health care company classified within the pharmaceuticals industry, though its specific operational activities and revenue generation mechanisms are not detailed in the available data.
Business. OCS.O is a health care company classified within the pharmaceuticals industry, though its specific operational activities and revenue generation mechanisms are not detailed in the available data.
Classification85 %
SectorHealth Care
Industry groupPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY12 analysts
12 buy0 hold0 sell
Avg 12m price target39,80
Analyst recommendations
12 analysts · consensus BuyBuy12
Hold0
Sell0
12-month price target
39,80
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
12 analysts · indicative
Ownership→
Wellington Management Company, LLP
largest disclosed fund holder
Profitability→
-50,5 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to OCS.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
OCS.O is a health care company classified within the pharmaceuticals industry, though its specific operational activities and revenue generation mechanisms are not detailed in the available data.
Classification85 %
SectorHealth Care
Industry groupPharmaceuticals
AI synthesis
GENERATED(a) Capital structure and liquidity: The company maintains a highly conservative balance sheet with a debt-to-equity ratio of 0.01 and a current ratio of 5.96, indicating strong short-term liquidity coverage. Total equity stands at CHF 196.07 million against total liabilities of CHF 39.89 million, with long-term debt minimal at CHF 2.31 million. Despite this strong liquidity position, the risk assessment flags medium liquidity risk, likely due to the negative net cash position after subtracting total debt, as operating cash flow is negative at CHF -66.30 million.
(b) Profitability and returns: The company is currently unprofitable, reporting an operating income of CHF -81.67 million and net income of CHF -98.96 million. This results in a negative return on equity of -50.47% and a negative return on assets of -41.94%. The valuation metrics reflect this pre-profitability status, with a negative EV/EBITDA of -22.55 and a high price-to-book ratio of 9.38, suggesting the market is pricing in significant future growth potential rather than current earnings power.
Key takeaways
- Strong balance sheet with minimal debt (D/E 0.01) and high current ratio (5.96) provides a buffer against short-term liquidity pressures.
- Significant unprofitability with net income of CHF -98.96 million and negative ROE (-50.47%) reflects a pre-revenue or heavy R&D phase.
- High valuation multiples (P/B 9.38) and negative EV/EBITDA indicate market pricing is based on future growth expectations rather than current fundamentals.
- Analyst consensus is overwhelmingly bullish with a mean recommendation of 1.50 and a mean price target of CHF 39.80, suggesting expected catalysts or milestones.
- Low dilution risk with no difference between basic and diluted shares, but negative free cash flow (CHF -99.80 million) necessitates ongoing capital management.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Quarterly
Annual
QUARTERLYFiled 2026-05-11
Q1 2026 · Quarter highlights
Operating income −8,8% YoY; Net income +13,1% YoY.
Revenue—
Operating income-CHF 21.7M−8,8 % YoY
Net income-CHF 28.9M+13,1 % YoY
Free cash flow-CHF 28.7M+16,0 % YoY
EPS—
Operating cash flow-CHF 15.3M+19,1 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 21.7M
Net income-CHF 28.9M
Balance sheet
Total assetsCHF 244.0M
Total liabilitiesCHF 47.3M
Total equityCHF 196.6M
Cash & equivalents—
Long-term debtCHF 2.2M
Cash flow
Operating cash flow-CHF 15.3M
CapEx-CHF 7.0k
Free cash flow-CHF 28.7M
SBC—
Highlights
- ▍Operating income −8,8% YoY
- ▍Net income +13,1% YoY
- ▍Free cash flow +16,0% YoY
QUARTERLYFiled 2026-03-03
Q4 2025 · Quarter highlights
Operating income −19,5% YoY; Net income +17,9% YoY.
Revenue—
Operating income-CHF 20.6M−19,5 % YoY
Net income-CHF 23.5M+17,9 % YoY
Free cash flow-CHF 23.4M+18,2 % YoY
EPS—
Operating cash flow-CHF 66.3M−35,5 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 20.6M
Net income-CHF 23.5M
Balance sheet
Total assetsCHF 236.0M
Total liabilitiesCHF 39.9M
Total equityCHF 196.1M
Cash & equivalents—
Long-term debtCHF 2.3M
Cash flow
Operating cash flow-CHF 66.3M
CapEx-CHF 1.4M
Free cash flow-CHF 23.4M
SBC—
Highlights
- ▍Operating income −19,5% YoY
- ▍Net income +17,9% YoY
- ▍Free cash flow +18,2% YoY
QUARTERLYFiled 2025-11-10
Q3 2025 · Quarter highlights
Operating income −11,9% YoY; Net income +16,5% YoY.
Revenue—
Operating income-CHF 20.3M−11,9 % YoY
Net income-CHF 16.9M+16,5 % YoY
Free cash flow-CHF 16.8M+16,8 % YoY
EPS—
Operating cash flow-CHF 49.6M−33,6 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 20.3M
Net income-CHF 16.9M
Balance sheet
Total assetsCHF 167.8M
Total liabilitiesCHF 37.2M
Total equityCHF 130.6M
Cash & equivalents—
Long-term debtCHF 2.5M
Cash flow
Operating cash flow-CHF 49.6M
CapEx-CHF 1.4M
Free cash flow-CHF 16.8M
SBC—
Highlights
- ▍Operating income −11,9% YoY
- ▍Net income +16,5% YoY
- ▍Free cash flow +16,8% YoY
QUARTERLYFiled 2025-08-21
Q2 2025 · Quarter highlights
Operating income +7,6% YoY; Net income −21,8% YoY.
Revenue—
Operating income-CHF 20.8M+7,6 % YoY
Net income-CHF 25.4M−21,8 % YoY
Free cash flow-CHF 25.4M−22,2 % YoY
EPS—
Operating cash flow-CHF 36.2M−35,5 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 20.8M
Net income-CHF 25.4M
Balance sheet
Total assetsCHF 181.6M
Total liabilitiesCHF 38.5M
Total equityCHF 143.1M
Cash & equivalents—
Long-term debtCHF 1.0M
Cash flow
Operating cash flow-CHF 36.2M
CapEx-CHF 1.2M
Free cash flow-CHF 25.4M
SBC—
Highlights
- ▍Operating income +7,6% YoY
- ▍Net income −21,8% YoY
- ▍Free cash flow −22,2% YoY
QUARTERLYFiled 2025-05-08
Q1 2025 · Quarter highlights
Operating income -CHF 20.0M.
Revenue—
Operating income-CHF 20.0M
Net income-CHF 33.2M
Free cash flow-CHF 34.2M
EPS—
Operating cash flow-CHF 19.0M
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 20.0M
Net income-CHF 33.2M
Balance sheet
Total assetsCHF 204.2M
Total liabilitiesCHF 41.5M
Total equityCHF 162.6M
Cash & equivalents—
Long-term debtCHF 1.1M
Cash flow
Operating cash flow-CHF 19.0M
CapEx-CHF 1.1M
Free cash flow-CHF 34.2M
SBC—
Highlights
- ▍Operating income -CHF 20.0M
QUARTERLYFiled 2025-03-11
Q4 2024 · Quarter highlights
Operating income -CHF 17.3M.
Revenue—
Operating income-CHF 17.3M
Net income-CHF 28.7M
Free cash flow-CHF 28.6M
EPS—
Operating cash flow-CHF 48.9M
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 17.3M
Net income-CHF 28.7M
Balance sheet
Total assetsCHF 120.4M
Total liabilitiesCHF 47.0M
Total equityCHF 73.4M
Cash & equivalents—
Long-term debtCHF 1.2M
Cash flow
Operating cash flow-CHF 48.9M
CapEx-CHF 230.0k
Free cash flow-CHF 28.6M
SBC—
Highlights
- ▍Operating income -CHF 17.3M
QUARTERLYFiled 2024-11-07
Q3 2024 · Quarter highlights
Operating income -CHF 18.1M.
Revenue—
Operating income-CHF 18.1M
Net income-CHF 20.2M
Free cash flow-CHF 20.2M
EPS—
Operating cash flow-CHF 37.1M
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 18.1M
Net income-CHF 20.2M
Balance sheet
Total assetsCHF 125.6M
Total liabilitiesCHF 30.4M
Total equityCHF 95.2M
Cash & equivalents—
Long-term debtCHF 1.2M
Cash flow
Operating cash flow-CHF 37.1M
CapEx-CHF 173.0k
Free cash flow-CHF 20.2M
SBC—
Highlights
- ▍Operating income -CHF 18.1M
QUARTERLYFiled 2024-08-27
Q2 2024 · Quarter highlights
Operating income -CHF 22.5M.
Revenue—
Operating income-CHF 22.5M
Net income-CHF 20.8M
Free cash flow-CHF 20.8M
EPS—
Operating cash flow-CHF 26.7M
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 22.5M
Net income-CHF 20.8M
Balance sheet
Total assetsCHF 138.7M
Total liabilitiesCHF 25.9M
Total equityCHF 112.8M
Cash & equivalents—
Long-term debtCHF 1.3M
Cash flow
Operating cash flow-CHF 26.7M
CapEx-CHF 19.0k
Free cash flow-CHF 20.8M
SBC—
Highlights
- ▍Operating income -CHF 22.5M
ANNUALFiled 2026-03-03
FY 2026 · Full-year highlights
Operating income −11,6% YoY; Net income −15,4% YoY.
Revenue—
Operating income-CHF 81.7M−11,6 % YoY
Net income-CHF 99.0M−15,4 % YoY
Free cash flow-CHF 99.8M−16,6 % YoY
EPS—
Operating cash flow-CHF 66.3M−35,5 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 81.7M
Net income-CHF 99.0M
Balance sheet
Total assetsCHF 236.0M
Total liabilitiesCHF 39.9M
Total equityCHF 196.1M
Cash & equivalents—
Long-term debtCHF 2.3M
Cash flow
Operating cash flow-CHF 66.3M
CapEx-CHF 1.4M
Free cash flow-CHF 99.8M
SBC—
Highlights
- ▍Operating income −11,6% YoY
- ▍Net income −15,4% YoY
- ▍Free cash flow −16,6% YoY
ANNUALFiled 2025-03-11
FY 2025 · Full-year highlights
Operating income +9,3% YoY; Net income +3,4% YoY.
Revenue—
Operating income-CHF 73.2M+9,3 % YoY
Net income-CHF 85.8M+3,4 % YoY
Free cash flow-CHF 85.6M+3,3 % YoY
EPS—
Operating cash flow-CHF 48.9M+11,1 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 73.2M
Net income-CHF 85.8M
Balance sheet
Total assetsCHF 120.4M
Total liabilitiesCHF 47.0M
Total equityCHF 73.4M
Cash & equivalents—
Long-term debtCHF 1.2M
Cash flow
Operating cash flow-CHF 48.9M
CapEx-CHF 230.0k
Free cash flow-CHF 85.6M
SBC—
Highlights
- ▍Operating income +9,3% YoY
- ▍Net income +3,4% YoY
- ▍Free cash flow +3,3% YoY
ANNUALFiled 2024-03-18
FY 2024 · Full-year highlights
Operating income −149,3% YoY; Net income −129,5% YoY.
Revenue—
Operating income-CHF 80.7M−149,3 % YoY
Net income-CHF 88.8M−129,5 % YoY
Free cash flow-CHF 88.6M−111,1 % YoY
EPS—
Operating cash flow-CHF 55.0M−119,5 % YoY
Financials
Income statement
Revenue—
Gross profit—
Operating income-CHF 80.7M
Net income-CHF 88.8M
Balance sheet
Total assetsCHF 114.4M
Total liabilitiesCHF 20.6M
Total equityCHF 93.7M
Cash & equivalents—
Long-term debtCHF 605.0k
Cash flow
Operating cash flow-CHF 55.0M
CapEx-CHF 48.0k
Free cash flow-CHF 88.6M
SBC—
Highlights
- ▍Operating income −149,3% YoY
- ▍Net income −129,5% YoY
- ▍Free cash flow −111,1% YoY
Valuation TTM
Market price
$12,90
Market cap
$1.84B
Enterprise valueⓘ
$1.84B
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
9.4x
P / Tangible bookⓘ
9.4x
Tangible book
$196.1M
Net cashⓘ
-$2.3M
Current ratioⓘ
6.0
Debt / equityⓘ
0.0
ROAⓘ
-41.9%
ROEⓘ
-50.5%
Cash conversionⓘ
67.0%
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-1,80
Predicted surprise
-0,03
Beat probability
45 %
Analysts
12
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
revision ratio -0,01 · as of 2026-07-28 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -1,80 |
| Revenue | —no estimate | —no estimate | 819,750 CHF |
| Operating income | —no estimate | —no estimate | -92,5M CHF |
Full-year consensus mean (period as reported by source) · consensus in CHF. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution12 analysts
Strong buy6
Buy6
Hold0
Sell0
Strong sell0
12-month price target$39,80 · Median $39,00
Low $26,00High $53,00
Operating income · consensus-92,5M CHF
EPS surprise
−5,1 %
reported vs consensus · miss
Revenue surprise
+36,5 %
reported vs consensus · beat
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$26,00
Mean$39,80
Median$39,00
High$53,00
Spot$12,90
+208.5 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
ROE-50,5 %Bottom quartile
D/E0,01Above median
Cash Conv0,67Below median
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
How metrics are computed
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
Source documents
- Oculis Holding AG Market data — financials · 2026-07-28
- reconciler_enqueue (reconciler) on OCS.O · 2026-07-28
- Oculis Holding AG Market data — analyst estimates · 2026-07-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,01 %$36M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
— missing data
Short positioning
1.5Mshares short+27.2% vs prior
3.98days to cover
42.3%short of daily vol
971fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
OCS.OCanonical
NASDAQ · USD
Intel & risk
What changed
no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)
- Narrative— → —medium
- Business summary— → —medium
- Conclusion— → —medium
- Key takeaways— → —medium
vs prior analysis 60 days ago
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data— missing data
The Thread
Everything we know, in order2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-05-11 16:05 UTCEARNINGSQuarterly results — Q1 2026 Net CHF -28.9M
2026-03-03 16:05 UTCEARNINGSQuarterly results — Q4 2025 Net CHF -23.5M
2026-03-03 16:05 UTCEARNINGSAnnual results — FY 2026 Net CHF -99.0M
2025-11-10 16:05 UTCEARNINGSQuarterly results — Q3 2025 Net CHF -16.9M
2025-08-21 16:05 UTCEARNINGSQuarterly results — Q2 2025 Net CHF -25.4M
2025-05-08 16:05 UTCEARNINGSQuarterly results — Q1 2025 Net CHF -33.2M
2025-03-11 16:30 UTCEARNINGSQuarterly results — Q4 2024 Net CHF -28.7M
2025-03-11 16:30 UTCEARNINGSAnnual results — FY 2025 Net CHF -85.8M
2024-11-07 04:00 UTCEARNINGSQuarterly results — Q3 2024 Net CHF -20.2M
2024-08-27 04:00 UTCEARNINGSQuarterly results — Q2 2024 Net CHF -20.8M
2024-03-18 06:30 UTCEARNINGSAnnual results — FY 2024 Net CHF -88.8M
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data
Premium coverage